Security key
297584104
Estrella Immunopharma, Inc. - Common Stock, par value $0.0001 per share (ESLA)
CUSIP: 297584104
Q1 2026 13F Holders as of 31 Mar 2026
- Security type / class
- Equity / Common Stock, par value $0.0001 per share
- Total 13F shares
- 5,178,824
- Total 13F value
- $5,489,554
- Share change
- +4,180,594
- SEC-reported price per share
- $1.06
- Number of holders
- 16
- Value change
- +$4,327,926
- Number of buys
- 9
- Number of sells
- 8
- Shares outstanding
- 41,110,401
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2026
Institutions
16
Top holders
10
ESLA full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2026
Previous quarter: Q4 2025
Estrella Immunopharma, Inc. SEC filings
Estrella Immunopharma, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 297584104
Recent filing periods:
Ownership snapshot
Top reported holders of ESLA - Estrella Immunopharma, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
VANGUARD GROUP INC
Disclosed value leader
VANGUARD GROUP INC
Comparable rows
15/15
Latest evidence
31 Dec 2025
13F
Lead comparable stake: 1.1%
Showing 1-6 of 15 holder rows.
Quick read
VANGUARD GROUP INC leads the comparable SEC ownership view at 1.1%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens VANGUARD GROUP INC's linked filing trail.
Comparable ownership
Top 5
VANGUARD GROUP INC
1.1%
RENAISSANCE TECHNOLOGIES LLC
0.3%
GEODE CAPITAL MANAGEMENT, LLC
0.27%
CITADEL ADVISORS LLC
0.16%
MARSHALL WACE, LLP
0.14%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| VANGUARD GROUP INC |
13F
Company
|
1.1%
|
$700,074
448,765 shares
|
— | 31 Dec 2025 |
| RENAISSANCE TECHNOLOGIES LLC |
13F
Company
|
0.3%
|
$191,050
122,468 shares
|
— | 31 Dec 2025 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
0.27%
|
$171,299
109,808 shares
|
— | 31 Dec 2025 |
| CITADEL ADVISORS LLC |
13F
Company
|
0.16%
|
$100,455
64,394 shares
|
— | 31 Dec 2025 |
| MARSHALL WACE, LLP |
13F
Company
|
0.14%
|
$87,728
56,236 shares
|
— | 31 Dec 2025 |
| XTX Topco Ltd |
13F
Company
|
0.12%
|
$77,176
49,472 shares
|
— | 31 Dec 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
16
Shares
5,178,824
Rows available
16
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2026 vs Q4 2025 Across Filers
Q4 2025 holders
15
Q1 2026 holders
16
Holder diff
1
| Investor | Q4 2025 Shares | Q1 2026 Shares | Share Diff | Share Chg % | Q4 2025 value | Q1 2026 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend